This is supported by another study using the CT26 colon cancer model that shows the role of VISTA in MDSC-mediated T-cell suppression under hypoxic conditions and indicates that targeting VISTA may counteract the dampening effect of hypoxia on antitumor immunity (23). Here, VSIR is linked to colonic neoplasm.